Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Murray Kwon"'
Autor:
Katia Bravo-Jaimes, Prashanth Venkatesh, Gentian Lluri, Leigh Reardon, Daniel Cruz, Darko Vucicevic, Eric H. Yang, Ali Nsair, Raj Saggar, Richard Channick, Murray Kwon, Glen Van Arsdell, Jamil Aboulhosn
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 8, Iss , Pp 100361- (2022)
Externí odkaz:
https://doaj.org/article/5dae1c12f754427691a7c1f78f7ab4d4
Autor:
Rhys J.P. Skelton, Bevin Brady, Suhail Khoja, Debashis Sahoo, James Engel, Deevina Arasaratnam, Kholoud K. Saleh, Oscar J. Abilez, Peng Zhao, Edouard G. Stanley, Andrew G. Elefanty, Murray Kwon, David A. Elliott, Reza Ardehali
Publikováno v:
Stem Cell Reports, Vol 6, Iss 1, Pp 95-108 (2016)
The generation of tissue-specific cell types from human embryonic stem cells (hESCs) is critical for the development of future stem cell-based regenerative therapies. Here, we identify CD13 and ROR2 as cell-surface markers capable of selecting early
Externí odkaz:
https://doaj.org/article/2d1db96c76b8472f8dd7cec5338423d6
Autor:
Galyna Bondar, Ryan Togashi, Martin Cadeiras, Joanna Schaenman, Richard K Cheng, Lindsay Masukawa, Josephine Hai, Tra-Mi Bao, Desai Chu, Eleanor Chang, Maral Bakir, Sophie Kupiec-Weglinski, Victoria Groysberg, Tristan Grogan, Joseph Meltzer, Murray Kwon, Maura Rossetti, David Elashoff, Elaine Reed, Pei Pei Ping, Mario C Deng
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189420 (2017)
Multiorgan dysfunction syndrome contributes to adverse outcomes in advanced heart failure (AdHF) patients after mechanical circulatory support (MCS) implantation and is associated with aberrant leukocyte activity. We tested the hypothesis that preope
Externí odkaz:
https://doaj.org/article/17f10160269349339040e36217babdb0
Autor:
William Toppen, Daniel Johansen, Sohail Sareh, Josue Fernandez, Nancy Satou, Komal D Patel, Murray Kwon, William Suh, Olcay Aksoy, Richard J Shemin, Peyman Benharash
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0173777 (2017)
BACKGROUND:Transcatheter aortic valve replacement (TAVR) has become a commonplace procedure for the treatment of aortic stenosis in higher risk surgical patients. With the high cost and steadily increasing number of patients receiving TAVR, emphasis
Externí odkaz:
https://doaj.org/article/7260dc6ee9ae453da470eaed8ce38142
Autor:
John Hollowed, Andre Akhondi, Amir Rabbani, Damla Oncel, William Suh, Asim Rafique, Murray Kwon, Peyman Benharash, Richard Shemin, Olcay Aksoy
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, vol 99, iss 7
IntroductionThe preferred approach for transcatheter aortic valve replacement (TAVR) is transfemoral. There has been widespread adoption of the Perclose ProglideTM device for vascular closure. Typically, two devices are deployed before upsizing the a
Autor:
Kalyanam Shivkumar, Murray Kwon, Peng Hu, Olujimi A. Ajijola, Noel G. Boyle, Jason S. Bradfield, Minsong Cao, Justin Hayase, Robert Chin
Publikováno v:
HeartRhythm Case Reports. 8:73-76
Autor:
Murray Kwon, Juka S. Kim, Elan Moreno, Richard J. Shemin, Reza Ardehali, Subeer K. Wadia, David Bae
Publikováno v:
Journal of Cardiac Surgery. 36:2722-2728
Objective Unrecognized left ventricular thrombi (LVT) can have devastating clinical implications and precludes patients with end-stage heart failure from undergoing left ventricular assist device (LVAD) implantation without cardiopulmonary bypass ass
Autor:
David G. Rabkin, Habib Khoury, Alexandra L. Mardock, Yas Sanaiha, Murray Kwon, Peyman Benharash, Bassam Omari, Sarah E. Rudasill
Publikováno v:
Surgery. 166:1142-1147
Occasionally, lung transplant candidates improve to the point where they are removed from the transplant list. We sought to determine the characteristics and outcomes of lung transplant candidates who improved to delisting both before and after imple
Publikováno v:
The UCLA Radiological Science Proceedings. 1
Author(s): Callese, Tyler; Padgett, Max; Kwon, Murray; Moriarty, John M | Abstract: Thoracic endovascular aortic repair (TEVAR) is the preferred treatment for ruptured thoracic aortic aneurysms. Poor access vessels are a relative contraindication to